kidney cancer

June 23, 2021 · Brielle Gregory Collins, ASCO staff
In this webinar, experts discuss new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting and the 2021 Genitourinary Cancers Symposium that highlighted advances in treating prostate, bladder, kidney, and testicular cancers. Read More >>
June 9, 2021 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Brian Shuch and genetic counselor Lauren Bear discuss genetic conditions linked to kidney cancer, how they can impact people with kidney cancer and their families, and what to expect if you’re referred to meet with a genetic counselor. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>
May 20, 2021 · Brielle Gregory Collins, ASCO staff
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatment options for kidney cancer, muscle-invasive bladder cancer, and metastatic castration-sensitive prostate cancer. Read More >>
December 21, 2020 · Brielle Gregory, ASCO staff
In the latest podcast in the “Clinical Trials in Genitourinary Cancers” series, experts discuss 3 clinical trials testing new treatments for prostate, bladder, and kidney cancers. Read More >>

Pages